Nothing Special   »   [go: up one dir, main page]

HUE046544T2 - Eljárások Hepatitis C kezelésére - Google Patents

Eljárások Hepatitis C kezelésére

Info

Publication number
HUE046544T2
HUE046544T2 HUE13773463A HUE13773463A HUE046544T2 HU E046544 T2 HUE046544 T2 HU E046544T2 HU E13773463 A HUE13773463 A HU E13773463A HU E13773463 A HUE13773463 A HU E13773463A HU E046544 T2 HUE046544 T2 HU E046544T2
Authority
HU
Hungary
Prior art keywords
methods
treating hepatitis
hepatitis
treating
Prior art date
Application number
HUE13773463A
Other languages
English (en)
Inventor
Teresa Ng (lok-Chan)
Tami J Pilot-Matias
Warren M Kati
Preethi Krishnan
Clarence J Maring
Neeta C Mistry
Thomas J Reisch
Rolf Wagner
Dachun Liu
John K Pratt
Mark A Matulenko
Ryan G Keddy
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49304326&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE046544(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbvie Inc filed Critical Abbvie Inc
Publication of HUE046544T2 publication Critical patent/HUE046544T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HUE13773463A 2012-09-18 2013-09-17 Eljárások Hepatitis C kezelésére HUE046544T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261702564P 2012-09-18 2012-09-18

Publications (1)

Publication Number Publication Date
HUE046544T2 true HUE046544T2 (hu) 2020-03-30

Family

ID=49304326

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13773463A HUE046544T2 (hu) 2012-09-18 2013-09-17 Eljárások Hepatitis C kezelésére

Country Status (25)

Country Link
US (1) US20140080868A1 (hu)
EP (2) EP2897611B1 (hu)
JP (4) JP6297044B2 (hu)
CN (1) CN104797253A (hu)
AU (2) AU2013318302B2 (hu)
BR (1) BR112015006037B1 (hu)
CA (1) CA2884539C (hu)
CY (1) CY1122442T1 (hu)
DK (1) DK2897611T3 (hu)
ES (1) ES2755089T3 (hu)
HK (1) HK1209319A1 (hu)
HR (1) HRP20191939T1 (hu)
HU (1) HUE046544T2 (hu)
LT (1) LT2897611T (hu)
MX (2) MX367796B (hu)
NZ (1) NZ630581A (hu)
PL (1) PL2897611T3 (hu)
PT (1) PT2897611T (hu)
RS (1) RS59640B1 (hu)
RU (1) RU2665365C2 (hu)
SG (2) SG11201502095SA (hu)
SI (1) SI2897611T1 (hu)
TW (1) TWI621436B (hu)
WO (1) WO2014047039A1 (hu)
ZA (1) ZA201501752B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE046544T2 (hu) * 2012-09-18 2020-03-30 Abbvie Inc Eljárások Hepatitis C kezelésére
US11484534B2 (en) 2013-03-14 2022-11-01 Abbvie Inc. Methods for treating HCV
SI3213750T1 (sl) * 2013-03-14 2020-11-30 Abbvie Inc. Kombinacija dveh antivirusnih sredstev za zdravljenje hepatitisa C
MX2016012722A (es) * 2014-04-02 2016-12-16 Abbvie Inc Metodos para tratar el virus de la hepatitis c.
MX2016012799A (es) 2014-04-02 2016-12-12 Abbvie Inc Metodos para tratar el virus de la hepatitis c.
US20160375017A1 (en) 2015-06-26 2016-12-29 Abbvie Inc. Solid Pharmaceutical Compositions for Treating HCV
CR20180030A (es) * 2015-06-26 2018-05-24 Abbvie Inc Composiciones farmacéuticas sólidas para el tratamiento del vhc.
US20180177779A1 (en) * 2015-07-08 2018-06-28 Abbvie Inc. Methods for Treating HCV
CA2992722C (en) * 2015-07-17 2023-10-17 Abbvie Inc. Solid pharmaceutical compositions for treating hcv
US11192914B2 (en) 2016-04-28 2021-12-07 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
JP2023553010A (ja) 2020-12-03 2023-12-20 バテル・メモリアル・インスティテュート 非ウイルス性送達のためのポリマーナノ粒子およびdnaナノ構造組成物ならびに方法
IL307454A (en) 2021-04-07 2023-12-01 Battelle Memorial Institute Technologies for rapid design, construction, testing, learning to identify and use non-viral vectors
GB202113944D0 (en) * 2021-09-29 2021-11-10 Univ Liverpool Injectable formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200800265A (en) * 2006-02-09 2008-01-01 Schering Corp Combinations comprising HCV protease inhibitor(s) and HCV polymerase inhibitor(s), and methods of treatment related thereto
AR075584A1 (es) * 2009-02-27 2011-04-20 Intermune Inc COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
US9394279B2 (en) * 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
AU2013201532B2 (en) * 2011-10-21 2014-10-02 Abbvie Ireland Unlimited Company Methods for treating HCV
HUE046544T2 (hu) * 2012-09-18 2020-03-30 Abbvie Inc Eljárások Hepatitis C kezelésére

Also Published As

Publication number Publication date
EP2897611A1 (en) 2015-07-29
WO2014047039A1 (en) 2014-03-27
EP2897611B1 (en) 2019-07-24
DK2897611T3 (da) 2019-11-04
JP6297044B2 (ja) 2018-03-20
AU2013318302A1 (en) 2015-04-02
CN104797253A (zh) 2015-07-22
JP2018109035A (ja) 2018-07-12
JP2019194241A (ja) 2019-11-07
TWI621436B (zh) 2018-04-21
RU2015114543A (ru) 2016-11-10
CA2884539A1 (en) 2014-03-27
MX2015003501A (es) 2015-10-26
CA2884539C (en) 2022-06-21
AU2018203608B2 (en) 2019-12-19
JP2015528511A (ja) 2015-09-28
SI2897611T1 (sl) 2019-12-31
RU2665365C2 (ru) 2018-08-29
JP6556884B2 (ja) 2019-08-07
US20140080868A1 (en) 2014-03-20
PL2897611T3 (pl) 2020-03-31
AU2018203608A1 (en) 2018-06-14
CY1122442T1 (el) 2021-01-27
HK1209319A1 (en) 2016-04-01
HRP20191939T1 (hr) 2020-01-10
MX367796B (es) 2019-09-06
NZ630581A (en) 2017-02-24
SG10201702248UA (en) 2017-04-27
ES2755089T3 (es) 2020-04-21
SG11201502095SA (en) 2015-05-28
TW201412311A (zh) 2014-04-01
ZA201501752B (en) 2016-08-31
RS59640B1 (sr) 2020-01-31
JP2021054849A (ja) 2021-04-08
AU2013318302B2 (en) 2018-02-22
MX2019010600A (es) 2020-02-03
BR112015006037A2 (pt) 2017-07-04
LT2897611T (lt) 2019-12-10
BR112015006037B1 (pt) 2022-05-17
PT2897611T (pt) 2019-11-27
EP3597190A1 (en) 2020-01-22

Similar Documents

Publication Publication Date Title
HRP20180237T1 (hr) Metode za liječenje hcv-a
HK1214504A1 (zh) 用於治療貧血的方法
HK1209745A1 (en) Compounds and methods for antiviral treatment
HK1209319A1 (en) Methods for treating hepatitis c
EP2757887A4 (en) PYRROLOPYRIDINONE COMPOUNDS AND METHOD FOR THE TREATMENT OF HIV
HK1198869A1 (en) Combination treatments for hepatitis c
ZA201906339B (en) Methods for treating pruritus
HK1209320A1 (en) Methods for treating hepatitis c
ZA201406172B (en) Compounds and methods for treating leukemia
HK1209040A1 (en) Methods for treating vestibulotoxicity
EP2854774A4 (en) METHODS OF TREATING INSOMNIA
GB201214387D0 (en) Methods for treating plants
GB201209932D0 (en) Improved process